Business
Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules
Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules.
About this update from Medical Care Technologies Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules\r\n \r\n \r\n\r\n\r\nMedical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules\r\n\r\n\r\n\r\n\r\n\r\nMESA, ARIZONA / ACCESS Newswire / October 8, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging innovator in AI-powered preventive healthcare, announced that it is preparing to conduct internal, non-clinical research studies on the consumer-facing components of its AI health platform - the Mental Health & Micro-Expression Tracker and the Preventive Health & Facial Biometrics Analyzer.\r\n These studies are part of the company's Consumer AI Division, which focuses on self-monitoring, behavioral research, and preventive awareness rather than clinical diagnosis. Both modules extend MDCE's broader vision of combining facial, ocular, and skin imaging analytics to forecast early health changes through accessible, camera-based AI tools.\r\n Research Overview:\r\n The Mental Health & Micro-Expression Tracker uses advanced facial landmark tracking and emotion-recognition networks to observe subtle shifts in stress, focus, and emotional balance.https://app.accessnewswire.com/imagelibrary/e3d62751-da70-44e3-8242-ec8fa5d03dd1/1081896/2.png \r\n \r\n \r\n The Preventive Health & Facial Biometrics Analyzer applies colorimetric and vascular mapping algorithms to evaluate visible wellness indicators such as tone, elasticity, and fatigue.https://app.accessnewswire.com/imagelibrary/c99464a5-300c-452d-ae65-6014722424e3/1081896/3.png \r\n \r\n \r\n Both will undergo self-conducted algorithmic testing to assess performance consistency and data reliability under diverse real-world conditions. Results will be used internally to refine MDCE's AI models and support future wellness-research collaborations.\r\n \"Our goal is to ensure that every module - clinical or consumer - meets a measurable standard of accuracy and transparency,\" said CEO Marshall Perkins III. \"These studies demonstrate our commitment to technical rigor and responsible AI development across all health verticals.\"\r\n Forward-Looking Statements / Safe Harbor\r\n This release...